ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE

Translated title of the contribution: Isotretinoin. Osseous and ligamentous alterations

C. Capobianco, V. Bettoli, U. Albisinni, L. Merlini, C. Vincenzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Thirty patients, affected by nodulo-cystic acne, were treated with isotretinoin for 3-7 months, at the average dosage of 0,5-0,7 mg/kg/day. These patients were studied in order to evaluate the prevalence of ossifications and/or calcifications of the spine. X-rays of the lumbar and cervical segment of the spine were performed 1-26 months after stopping therapy. In 17 out of 30 patients X-rays were also performed before treatment. No pathological alterations, either vertebral or ligamentous, were evident.

Original languageItalian
Pages (from-to)291-293
Number of pages3
JournalGiornale Italiano di Dermatologia e Venereologia
Volume126
Issue number6
Publication statusPublished - 1991

Fingerprint

Isotretinoin
Spine
X-Rays
Acne Vulgaris
Osteogenesis
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Capobianco, C., Bettoli, V., Albisinni, U., Merlini, L., & Vincenzi, C. (1991). ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE. Giornale Italiano di Dermatologia e Venereologia, 126(6), 291-293.

ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE. / Capobianco, C.; Bettoli, V.; Albisinni, U.; Merlini, L.; Vincenzi, C.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 126, No. 6, 1991, p. 291-293.

Research output: Contribution to journalArticle

Capobianco, C, Bettoli, V, Albisinni, U, Merlini, L & Vincenzi, C 1991, 'ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE', Giornale Italiano di Dermatologia e Venereologia, vol. 126, no. 6, pp. 291-293.
Capobianco C, Bettoli V, Albisinni U, Merlini L, Vincenzi C. ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE. Giornale Italiano di Dermatologia e Venereologia. 1991;126(6):291-293.
Capobianco, C. ; Bettoli, V. ; Albisinni, U. ; Merlini, L. ; Vincenzi, C. / ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE. In: Giornale Italiano di Dermatologia e Venereologia. 1991 ; Vol. 126, No. 6. pp. 291-293.
@article{5b17f74e972544d0ad46fc919f57854d,
title = "ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE",
abstract = "Thirty patients, affected by nodulo-cystic acne, were treated with isotretinoin for 3-7 months, at the average dosage of 0,5-0,7 mg/kg/day. These patients were studied in order to evaluate the prevalence of ossifications and/or calcifications of the spine. X-rays of the lumbar and cervical segment of the spine were performed 1-26 months after stopping therapy. In 17 out of 30 patients X-rays were also performed before treatment. No pathological alterations, either vertebral or ligamentous, were evident.",
author = "C. Capobianco and V. Bettoli and U. Albisinni and L. Merlini and C. Vincenzi",
year = "1991",
language = "Italian",
volume = "126",
pages = "291--293",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - ISOTRETINOINA. ALTERAZIONI OSSEE E LEGAMENTOSE

AU - Capobianco, C.

AU - Bettoli, V.

AU - Albisinni, U.

AU - Merlini, L.

AU - Vincenzi, C.

PY - 1991

Y1 - 1991

N2 - Thirty patients, affected by nodulo-cystic acne, were treated with isotretinoin for 3-7 months, at the average dosage of 0,5-0,7 mg/kg/day. These patients were studied in order to evaluate the prevalence of ossifications and/or calcifications of the spine. X-rays of the lumbar and cervical segment of the spine were performed 1-26 months after stopping therapy. In 17 out of 30 patients X-rays were also performed before treatment. No pathological alterations, either vertebral or ligamentous, were evident.

AB - Thirty patients, affected by nodulo-cystic acne, were treated with isotretinoin for 3-7 months, at the average dosage of 0,5-0,7 mg/kg/day. These patients were studied in order to evaluate the prevalence of ossifications and/or calcifications of the spine. X-rays of the lumbar and cervical segment of the spine were performed 1-26 months after stopping therapy. In 17 out of 30 patients X-rays were also performed before treatment. No pathological alterations, either vertebral or ligamentous, were evident.

UR - http://www.scopus.com/inward/record.url?scp=0025817773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025817773&partnerID=8YFLogxK

M3 - Articolo

VL - 126

SP - 291

EP - 293

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 6

ER -